EBBC ‘s broad-spectrum virucidal activity is promising for the prevention of respiratory infections, particularly given lysozyme’s established efficacy against various strains of influenza A viruses and even avian flu viruses like H5N1, H5N6, and H7N1 (Bergamo and Sava, 2024; Huang et al., 2023). Here, LYZ is linked to respiratory tract infectious disorder.